Rankings
▼
Calendar
NAGE Q4 2016 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
+29.3% YoY
Gross Profit
$2M
40.8% margin
Operating Income
-$2M
-37.6% margin
Net Income
-$2M
-38.0% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+43.3%
Cash Flow
Operating Cash Flow
$191,186
Free Cash Flow
-$387,758
Stock-Based Comp.
$263,756
Balance Sheet
Total Assets
$20M
Total Liabilities
$10M
Stockholders' Equity
$10M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$4M
+29.3%
Gross Profit
$2M
$2M
+43.6%
Operating Income
-$2M
-$1M
-71.2%
Net Income
-$2M
-$1M
-50.5%
← FY 2016
All Quarters
Q1 2017 →